tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market
Advertisement

Iradimed (IRMD) Ratios

Compare
163 Followers

Iradimed Ratios

IRMD's free cash flow for Q2 2025 was $0.78. For the 2025 fiscal year, IRMD's free cash flow was decreased by $ and operating cash flow was $0.36. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.78 4.65 9.14 11.18 12.96
Quick Ratio
7.51 3.87 8.51 10.54 12.16
Cash Ratio
6.01 3.05 6.78 9.09 10.18
Solvency Ratio
1.80 0.87 1.14 0.93 0.20
Operating Cash Flow Ratio
3.08 0.82 1.17 1.65 1.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 65.23M$ 55.27M$ 66.35M$ 65.54M$ 54.05M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.02 0.03 0.03 0.04
Debt-to-Equity Ratio
0.00 0.03 0.03 0.03 0.04
Debt-to-Capital Ratio
0.00 0.03 0.03 0.03 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.29 1.16 1.15 1.16
Debt Service Coverage Ratio
0.00 0.00 22.25 0.00 0.00
Interest Coverage Ratio
0.00 0.00 26.86 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.16 0.22 0.20 0.22
Net Debt to EBITDA
-1.98 -2.29 -3.42 -5.30 -81.26
Profitability Margins
Gross Profit Margin
76.96%76.50%77.45%76.65%74.33%
EBIT Margin
32.73%30.56%29.32%23.52%-2.38%
EBITDA Margin
34.39%31.73%30.58%26.84%1.84%
Operating Profit Margin
30.67%30.56%29.32%23.48%-2.38%
Pretax Profit Margin
33.54%33.16%30.36%23.52%-1.94%
Net Profit Margin
26.61%26.22%24.07%22.30%4.32%
Continuous Operations Profit Margin
26.61%26.22%24.07%22.30%4.32%
Net Income Per EBT
79.34%79.09%79.28%94.81%-221.92%
EBT Per EBIT
109.35%108.50%103.54%100.19%81.59%
Return on Assets (ROA)
19.41%18.66%15.00%11.25%1.93%
Return on Equity (ROE)
23.30%24.07%17.41%12.92%2.23%
Return on Capital Employed (ROCE)
24.39%26.42%20.31%12.91%-1.14%
Return on Invested Capital (ROIC)
19.35%20.78%16.04%12.19%2.53%
Return on Tangible Assets
20.04%19.18%15.37%11.41%1.95%
Earnings Yield
2.30%2.87%3.61%1.63%0.50%
Efficiency Ratios
Receivables Turnover
7.11 5.36 4.02 8.14 6.93
Payables Turnover
9.41 8.29 6.68 12.47 12.39
Inventory Turnover
1.60 1.20 2.24 2.27 2.07
Fixed Asset Turnover
3.38 5.79 22.21 9.19 6.56
Asset Turnover
0.73 0.71 0.62 0.50 0.45
Working Capital Turnover Ratio
1.15 1.01 0.77 0.65 0.57
Cash Conversion Cycle
241.14 327.85 199.30 176.30 199.53
Days of Sales Outstanding
51.35 68.06 90.90 44.84 52.65
Days of Inventory Outstanding
228.58 303.80 163.03 160.73 176.34
Days of Payables Outstanding
38.80 44.00 54.63 29.26 29.45
Operating Cycle
279.93 371.85 253.93 205.56 228.98
Cash Flow Ratios
Operating Cash Flow Per Share
2.13 1.07 0.80 0.91 0.48
Free Cash Flow Per Share
1.07 0.43 0.65 0.85 0.43
CapEx Per Share
1.07 0.64 0.15 0.06 0.05
Free Cash Flow to Operating Cash Flow
0.50 0.41 0.81 0.93 0.89
Dividend Paid and CapEx Coverage Ratio
1.25 0.63 0.70 15.18 9.14
Capital Expenditure Coverage Ratio
2.00 1.68 5.36 15.18 9.14
Operating Cash Flow Coverage Ratio
0.00 6.59 4.55 4.54 2.14
Operating Cash Flow to Sales Ratio
0.35 0.21 0.19 0.27 0.18
Free Cash Flow Yield
1.51%0.91%2.30%1.84%1.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
43.41 34.80 27.70 61.18 201.91
Price-to-Sales (P/S) Ratio
11.56 9.13 6.67 13.64 8.72
Price-to-Book (P/B) Ratio
9.51 8.38 4.82 7.90 4.50
Price-to-Free Cash Flow (P/FCF) Ratio
66.20 109.62 43.51 54.25 53.35
Price-to-Operating Cash Flow Ratio
33.04 44.43 35.39 50.68 47.51
Price-to-Earnings Growth (PEG) Ratio
11.36 1.04 0.81 0.10 -2.32
Price-to-Fair Value
9.51 8.38 4.82 7.90 4.50
Enterprise Value Multiple
31.62 26.47 18.39 45.53 393.08
Enterprise Value
844.15M 550.54M 299.65M 511.00M 229.06M
EV to EBITDA
31.62 26.47 18.39 45.53 393.08
EV to Sales
10.87 8.40 5.62 12.22 7.22
EV to Free Cash Flow
62.29 100.87 36.69 48.59 44.21
EV to Operating Cash Flow
31.10 40.89 29.84 45.39 39.37
Tangible Book Value Per Share
7.15 5.47 5.70 5.76 4.98
Shareholders’ Equity Per Share
7.42 5.67 5.86 5.85 5.06
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.21 0.05 3.22
Revenue Per Share
6.11 5.20 4.24 3.39 2.62
Net Income Per Share
1.62 1.36 1.02 0.76 0.11
Tax Burden
0.79 0.79 0.79 0.95 -2.22
Interest Burden
1.02 1.08 1.04 1.00 0.82
Research & Development to Revenue
0.03 0.04 0.04 0.05 0.06
SG&A to Revenue
0.22 0.23 0.20 0.23 0.39
Stock-Based Compensation to Revenue
0.04 0.03 0.03 0.03 0.12
Income Quality
1.31 0.78 0.78 1.21 4.25
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis